Healthcare >> CEO Interviews >> October 26, 2004

Uli Hacksell – Acadia Pharmaceuticals Inc (acad)

ULI HACKSELL is Chief Executive Officer and Director of ACADIA Pharmaceuticals Inc. He joined ACADIA as Executive Vice President of Drug Discovery in February 1999 and was elected Chief Executive Officer in September 2000. Prior to joining ACADIA, Dr. Hacksell held various senior executive positions at Astra, including the corporate position of Vice President of Drug Discovery Technology and President of Astra Draco. He has also served as Vice President of CNS Preclinical R&D at Astra Arcus. Earlier in his career, Dr. Hacksell held the positions of Professor of Organic Chemistry and Chairman at Uppsala University in Sweden and also served as Chairman of the European Federation of Medicinal Chemistry. He has authored about 200 publications. Dr. Hacksell received a Doctor of Pharmacy and a PhD in Medicinal Chemistry at Uppsala University. Profile
TWST: Would you begin with a brief history of ACADIA Pharmaceuticals and

an overview of your products?

Dr. Hacksell: ACADIA is a biopharmaceutical company utilizing innovative

technology to